Cinque Partners’s Pfizer PFE Stock Holding History

Cinque Partners’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-19,694	Closed	-$587K	–	46
2015 Q3	$587K	Hold	19,694	–	–	0.99%	44
2015 Q2	$627K	Hold	19,694	–	–	0.98%	46
2015 Q1	$650K	Sell	19,694 -33,795	-63%	-$1.07M	1%	33
2014 Q4	$1.58M	Sell	53,489 -8,870	-14%	-$254K	0.93%	34
2014 Q3	$1.75M	Buy	62,359 +360	+0.6%	+$10.1K	0.92%	36
2014 Q2	$1.75M	Buy	61,999 +940	+2%	+$26.8K	0.9%	39
2014 Q1	$1.86M	Sell	61,059 -6,505	-10%	-$194K	1.01%	35
2013 Q4	$1.96M	Buy	67,564 +11,147	+20%	+$324K	1%	37
2013 Q3	$1.54M	Sell	56,417 -49,666	-47%	-$1.35M	1.03%	35
2013 Q2	$2.82M	Buy	+106,083	New	+$2.93M	1.7%	23

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Cinque Partners's PFE Position: Q4 2015 in Review

Cinque Partners sold out of Pfizer (PFE) in Q4 2015, closing a stake of 19,694 shares — an estimated $587K sold.

Cinque Partners first reported a position in PFE in Q2 2013 and held it in 10 quarters. The position peaked at $2.82M in Q2 2013. 1,969 funds tracked by Wall St. Rank hold PFE as of Q4 2015.

Cinque Partners reported no remaining Pfizer position as of Q4 2015 after selling out during the quarter.
Cinque Partners sold 19,694 Pfizer shares in Q4 2015, an estimated $587K.
Cinque Partners first reported a position in Pfizer in Q2 2013 and held it in 10 quarters.
Cinque Partners's Pfizer position peaked at $2.82M in Q2 2013.
1,969 funds tracked by Wall St. Rank held Pfizer as of Q4 2015.

Based on Cinque Partners's 13F filing for Q4 2015, filed 12 Feb 2016.